In VitroRelease Kinetics of Antituberculosis Drugs from Nanoparticles Assessed Using a Modified Dissolution Apparatus
Open Access
- 1 January 2013
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2013, 1-9
- https://doi.org/10.1155/2013/136590
Abstract
The aim of this study was to assess thein vitrorelease kinetics of antituberculosis drug-loaded nanoparticles (NPs) using a “modified” cylindrical apparatus fitted with a regenerated cellulose membrane attached to a standard dissolution apparatus (modifiedcylinder method). The model drugs that were used were rifampicin (RIF) and moxifloxacin hydrochloride (MX). Gelatin and polybutyl cyanoacrylate (PBCA) NPs were evaluated as the nanocarriers, respectively. The dissolution and release kinetics of the drugs from loaded NPs were studied in different media using the modified cylinder method and dialysis bag technique was used as the control technique. The results showed that use of the modified cylinder method resulted in different release profiles associated with unique release mechanisms for the nanocarrier systems investigated. The modified cylinder method also permitted discrimination between forced and normalin vitrorelease of the model drugs from gelatin NPs in the presence or absence of enzymatic degradation. The use of dialysis bag technique resulted in an inability to differentiate between the mechanisms of drug release from the NPs in these cases. This approach offers an effective tool to investigatein vitrorelease of RIF and MX from NPs, which further indicate that this technique can be used for performance testing of nanosized carrier systems.Keywords
Funding Information
- Innovation Centre of the University of Alberta
This publication has 28 references indexed in Scilit:
- Supramolecular assemblies of rifampicin and cationic bilayers: preparation, characterization and micobactericidal activityBMC Biotechnology, 2011
- Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for TuberculosisAntimicrobial Agents and Chemotherapy, 2011
- Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus IDrug Development and Industrial Pharmacy, 2010
- DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution ProfilesThe AAPS Journal, 2010
- Biowaiver monographs for immediate release solid oral dosage forms: RifampicinJournal of Pharmaceutical Sciences, 2009
- Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systemsAdvanced Drug Delivery Reviews, 2006
- In vitro release dynamics of an anticancer drug from swellable gelatin nanoparticlesJournal of Applied Polymer Science, 2006
- Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage formsBiopharmaceutics & Drug Disposition, 2005
- Protonation equilibrium and lipophilicity of moxifloxacinJournal of Pharmaceutical and Biomedical Analysis, 2005
- The Use of New Polymethylmethacrylate Adjuvants for Split Influenza VaccinesPathobiology, 1976